Skip to main content

Good practices for Ga-68 radiopharmaceutical production: an important correction

To the editor

The review titled “Good practices for 68Ga radiopharmaceutical production” by Nelson et al. (2022) and published in the latest issue of your journal contains important information about 68Ga radiopharmaceuticals. However, sentence of the “These 68Ga radiopharmaceuticals include agents such as [68Ga]Ga-macroaggregated albumin for myocardial perfusion evaluation…” contradicts basic nuclear medicine knowledges.

68Ga-macroaggregated albumin is stated to be a potential radiopharmaceutical in lung perfusion studies in preclinical and clinical studies (Gültekin et al. 2020; Ament et al. 2013). 68Ga-macroaggregated albumin is not used in myocardial perfusion studies. I think that this error maybe caused by inattention of the author and in the review processes, and I would like to point out that it would be useful to correct it.

Availability of data and materials

Not applicable.

References

Download references

Acknowledgements

Not applicable.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

AG was responsible for writing and editing the manuscript. The author read and approved the final manuscript.

Corresponding author

Correspondence to Aziz Gültekin.

Ethics declarations

Ethical approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The author declares that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gültekin, A. Good practices for Ga-68 radiopharmaceutical production: an important correction. EJNMMI radiopharm. chem. 8, 1 (2023). https://doi.org/10.1186/s41181-022-00184-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s41181-022-00184-x